Venous thromboembolism in children with lower limb fractures: A systematic review and meta-analysis.

Injury · Jun 03 2026 · Recent

Habib Z, Ahmed EM, Zipitis CS, Sutton PM, Malik RA, Charalambous CP

Trauma and Orthopaedics, Blackpool Teaching Hospitals NHS Trust, Blackpool, UK

Orthopaedic Trauma Pediatric Orthopaedics

SUMMARY — THE REDUCTIONVenous thromboembolism occurs infrequently in children with lower limb fractures at 0.53% rate; evidence for pharmacological prophylaxis remains sparse.
Abstract, as published

OBJECTIVES: There is limited evidence regarding Venous Thromboembolism (VTE) in children with lower limb fractures. Our primary objective was to assess the rate, risk factors, mortality and role of pharmacological prophylaxis of VTE in children with lower limb fractures.

METHODS: Systematic review and meta-analysis. PubMed, CINAHL, and Cochrane CENTRAL were searched. Full published studies reporting on the rate of venous thromboembolism and/or on the efficacy of chemical thromboprophylaxis in children with lower limb fractures. Data extraction and quality appraisal were performed. Meta-analysis was conducted using a random effects model. The protocol was prospectively registered with PROSPERO (CRD42021278566).

RESULTS: Literature search identified 8342 articles of which 8 were included. All included studies were retrospective and studied paediatric populations in the USA and China. Meta-analysis of 5 studies reporting on children aged equal to or less than 18 years showed an overall estimated VTE rate of 0.53% (95%CI 0.20-1.38). There was sparse evidence related to risk factors for VTE and mortality rates in this patient population, and no evidence related to the impact of VTE prophylaxis.

CONCLUSIONS: VTE is a recognised occurrence in children with lower limb fractures, but it is estimated to be infrequent. There is a need for high-quality research to further evaluate the rates of VTE in subgroups of paediatric patients as well as to determine the risk factors, mortality and efficacy of pharmacological prophylaxis. Individualised assessment and management is recommended in the meantime.

LEVEL OF EVIDENCE: Level III, systematic review of Level III retrospective studies.

Featured in the 2026-07-20 issue.

← Key aspects of soft tissue management in fracture-related inf…Is the use of retrospectively collected radiographic scores a… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.